Pharmaceutical Sector Soars in India: A Look at Crocin API's 1.1 Lakh Crore Market Cap & 19.7-24% RO

As India's pharmaceutical sector makes waves in 2025, one company stands out for its remarkable growth trajectory, with a market cap of ₹1.1 lakh crore and ROE at an all-time high.

  • Here are 22 clean bullet points summarizing the video:
  • The pharmaceutical sector is making waves in India in 2025.
  • The government is pushing India to become a pharmacy of the antique region.
  • Many PLI skims have been introduced by the government for the pharma industry.
  • B.L. Quit this Company was founded in 1995 by Rajiv Juneja, who dropped out of college at age 18.
  • Initially, the company had a valuation of ₹50 lakh and has since grown to a market cap of around ₹1.1 lakh crore.
  • API (Active Pharmaceutical Ingredients) is what actually causes the therapeutic effect.
  • Examples of APIs include Crocin, Curcine, and Hedech.
  • Short-term diseases are often treated with APIs.
  • Companies like Mainkind Pharma invest heavily in research and development.
  • The company's revenue has grown significantly from ₹22-23 to ₹24 (2023-2024).
  • The company has a good market cap of around ₹1.1 lakh crore, making it a large-cap company.
  • The ROE (Return on Equity) is 19.7%, and the ROCE (Return on Capital Employed) is 24%.
  • The share holding pattern shows that promoter holdings are at 76.5%.
  • The hope is that the promoter holding will not drop below 75%.
  • There has been a recent acquisition in Q3 results.
  • The speaker advises checking weather to weather and acting quickly, as the world is moving fast.
  • A final goodbye is given with the phrase "Till Den Tech Care Jai Hind and Bye".

Source: CA Rachana Phadke Ranade via YouTube

❓ What do you think? What are the potential consequences of India's push to become a pharmacy hub for the Asian continent on the pharmaceutical sector as a whole? Feel free to share your thoughts in the comments!